Targeting FGF1-FGFR2 via RORγ Halts Cholangiocarcinoma
In a compelling advancement for liver cancer therapeutics, researchers have unveiled a novel molecular axis involving Fibroblast Growth Factor 1 ...
In a compelling advancement for liver cancer therapeutics, researchers have unveiled a novel molecular axis involving Fibroblast Growth Factor 1 ...
